Evaluation and Management of Gross Hematuria
All patients with gross hematuria require a complete urologic workup including imaging and cystoscopy, as the malignancy risk is 30-40%. 1
Initial Clinical Assessment
Begin by obtaining specific historical details that stratify malignancy risk:
- Age >35 years (critical threshold)
- Male gender
- Smoking history
- Occupational chemical exposures
- Analgesic abuse
- Prior urologic disease
- Irritative voiding symptoms
- History of pelvic irradiation
- Chronic UTIs
- Chemotherapy exposure (especially cyclophosphamide)
- Chronic indwelling catheters 1
Perform urinalysis with microscopy and urine culture. Obtain serum creatinine to assess renal function. Physical examination should include pelvic examination in women and rectal examination in men to evaluate for benign prostatic hyperplasia or pelvic masses 1.
Imaging Protocol
CT urography (CTU) is the imaging modality of choice for gross hematuria. 1
CTU must include:
- Unenhanced phase (to detect stones)
- Nephrographic phase (for renal parenchymal evaluation)
- Excretory phase (acquired ≥5 minutes post-contrast for urothelial visualization)
- Thin-slice acquisition with maximum intensity projection or 3-D volume rendering 1
Alternative imaging approaches:
- MR urography if contrast allergy or radiation concerns exist
- Ultrasound alone is inadequate for complete evaluation of gross hematuria 2
Cystoscopy
Cystoscopy is mandatory in addition to imaging to evaluate the bladder and urethra, as imaging alone cannot adequately assess these structures 1. This should be performed by urology, typically as an outpatient procedure unless the patient is unstable.
Special Considerations
Anticoagulation
Do not defer workup in anticoagulated patients—anticoagulation does not alter the evaluation algorithm, as underlying pathology must still be excluded 1.
Suspected Infection
If UTI is suspected, obtain urine culture before starting antibiotics. However, gross hematuria still mandates full urologic evaluation even if infection is present 1.
Renal Parenchymal Disease
If proteinuria, dysmorphic RBCs, or RBC casts suggest glomerular disease, initiate concurrent nephrology evaluation. However, this does not preclude urologic workup—both evaluations should proceed in parallel 1.
Age <40 Years
While malignancy risk is lower in younger patients, gross hematuria still requires evaluation. Consider stones, infection, and trauma more prominently, but do not skip imaging and cystoscopy if no obvious benign cause is identified 2.
Urgent Referral Indications
Immediate urology referral is indicated for:
- All gross hematuria cases
- Hemodynamic instability or bladder tamponade requiring catheterization
- Acute urinary retention
- Suspected trauma with imaging findings
- Anemia requiring transfusion 3, 4, 5
Common Pitfalls
Critical error: Assuming anticoagulation explains the hematuria. Up to 40% of anticoagulated patients with gross hematuria have significant urologic pathology including malignancy 1.
Do not obtain voided urine cytology as part of initial screening—it lacks sensitivity to rule out malignancy and adds no value to the diagnostic pathway 5.
Do not use CT abdomen/pelvis with contrast alone—this is insufficient. The protocol must specifically include unenhanced and excretory phases (true CTU protocol) to adequately evaluate the entire urinary tract 1.
Disposition
Most patients with gross hematuria can be discharged with urgent outpatient urology follow-up (within 1-2 weeks) if hemodynamically stable, able to void, and without evidence of obstruction or severe anemia. Ensure adequate hydration and avoid aspirin/NSAIDs if possible 3, 4.